Piramal Pharma hits record high in weak market; surges 12% on heavy volumes

Quick Summary:

As many as 43.42 million equity shares, representing 3.

The company sees promising growth opportunities for all three business verticals and is strategically making investments to strengthen its capabilities and capacities, analysts said.

Piramal Pharma hits record high in weak market; surges 12% on heavy volumesAs many as 43.42 million equity shares, representing 3.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Complex hospital generics Piramal Critical Care Contract development and manufacturing organisation CDMO Piramal Pharma Solutions Establishment inspection report USFDA Voluntary action indicated Piramal Pharma share HDFC Mutual Fund Wellness products VAI ICH EIR PPL PCC CHG business India Consumer Healthcare Piramal Group PPS

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-04 @ 14:20:00 (9 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 635 words

Reading Time: 4 minutes read

Sentences: 21 lines

Sentence Length: 31 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22364717

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 287 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions